Timeline
2019
2020
- Langen Junior Science Award
- WHO Declares Pandemic
- Paul Ehrlich and Ludwig Darmstaedter Prize
- Supply Bottleneck for Pneumococcal Vaccines
- Blood Donation Remains Possible
- Convalescent Plasma: First Clinical Trial
- COVID-19 Vaccines: First Clinical Trial
- Marketing Authorisation of Gene Therapy
- COVID-19 Vaccines: Second Clinical Trial Approved
- German Presidency of the EU Council
- COVID-19 Vaccines: Two Clinical Trials Approved
- Another Clinical Trial Approved
- Start of Two Rolling Review Procedures
- Allergen Products: European Standards
- Allergen Product: First European Marketing Authorisation
- COVID-19 Peptide Vaccine: First Clinical Trial
- COVID-19 Vaccine: Third Rolling Review Procedure
- Validation of COVID-19 Rapid Tests
- First Marketing Authorisation of a COVID-19 Vaccine
- SafeVac App Available
On 1 August 2019 the new German Haemophilia Registry (DHR) at the Paul-Ehrlich-Institut goes online. For ten years, the DHR has been collecting therapy-relevant data from patients with haemostasis (blood coagulation) disorders, such as haemophilia A and B. Experts from the Haematology / Transfusion Medicine division have refined the database to enable it to meet the current challenges. As a result, not only can supply be monitored, but the development of new treatments can also be supported and data can be collected for research into rare diseases.